Clinical Trial Update: Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of irinotecan in metastatic or inoperable thyroid cancer was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-12-06